Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep1053 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Gliptin-associated bullous pemphigoid: about two cases

Bessaad Lina , Chaabouni Rim , Cherif Malek , Mouhaymen MISSAOUI Abdel , Amine Fouad Mohamed , Sellami Khadija , Hammami Fatma , Masmoudi Abderrahmen , Rekik Nabila , Turki Hamida

Introduction & Objective: Bullous pemphigoid (BP) is a chronic immune-mediated blistering disease that mainly affects the elderly. This affection can be triggered by multiple factors such as drugs. Gliptins are one of the most incriminated drugs in the drug-induced bullous pemphigoid (DIBP). Our objective was to determine the characteristics of this pathology associated with the use of this medication through two cases of BP confirmed by histology and direct immunofluoresc...

ea0090ep510 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

New indication for long-acting second-generation basalinsulin analog?

Elleuch Mouna , Chehaider Cyrine , Souhir Maalej , Lachiheb Nabil , Ben Salah Dhoha , Atheymen Rim , Charfi Nadia , Mnif Mouna , Mnif Fatma , Masmoudi Abderrahmen , Gouiaa Naourez , Sahnoun Zouhair , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Although skin reactions relating to insulin injection have decreased since the prescription of human insulin and the use of highly purified insulin, they are still described in the literature. They can lead to significant problems with glycemic control. The challenge is to recognize the type of reaction that is occurring and identify the type of insulin formulation that avoids these reactions.Case-report: A 64-year-old patient, with type 2 ...